Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 29437 | 27.75 |
09:34 ET | 400 | 27.735 |
09:36 ET | 9326 | 27.66 |
09:38 ET | 37914 | 27.58 |
09:39 ET | 3009 | 27.51 |
09:41 ET | 3982 | 27.595 |
09:43 ET | 1669 | 27.66 |
09:45 ET | 1207 | 27.62 |
09:48 ET | 907 | 27.64 |
09:50 ET | 500 | 27.65 |
09:52 ET | 4422 | 27.675 |
09:54 ET | 1800 | 27.69 |
09:56 ET | 5194 | 27.74 |
09:57 ET | 2334 | 27.7 |
09:59 ET | 3490 | 27.7 |
10:01 ET | 2588 | 27.7 |
10:03 ET | 6655 | 27.69 |
10:06 ET | 3200 | 27.7 |
10:08 ET | 4223 | 27.675 |
10:10 ET | 11645 | 27.57 |
10:12 ET | 9370 | 27.59 |
10:14 ET | 500 | 27.58 |
10:15 ET | 1889 | 27.615 |
10:17 ET | 3831 | 27.6 |
10:19 ET | 650 | 27.58 |
10:21 ET | 1834 | 27.56 |
10:24 ET | 7801 | 27.52 |
10:26 ET | 13938 | 27.5 |
10:28 ET | 13998 | 27.43 |
10:30 ET | 9456 | 27.406 |
10:32 ET | 7403 | 27.39 |
10:33 ET | 6247 | 27.405 |
10:35 ET | 5201 | 27.395 |
10:37 ET | 11785 | 27.385 |
10:39 ET | 8956 | 27.445 |
10:42 ET | 15823 | 27.385 |
10:44 ET | 13357 | 27.415 |
10:46 ET | 17507 | 27.42 |
10:48 ET | 4770 | 27.43 |
10:50 ET | 4174 | 27.4 |
10:51 ET | 14118 | 27.41 |
10:53 ET | 3125 | 27.4 |
10:55 ET | 8252 | 27.355 |
10:57 ET | 3268 | 27.36 |
11:00 ET | 4373 | 27.36 |
11:02 ET | 3242 | 27.33 |
11:04 ET | 2096 | 27.35 |
11:06 ET | 4971 | 27.34 |
11:08 ET | 2802 | 27.35 |
11:09 ET | 5263 | 27.35 |
11:11 ET | 7139 | 27.39 |
11:13 ET | 13036 | 27.36 |
11:15 ET | 10178 | 27.3875 |
11:18 ET | 4456 | 27.39 |
11:20 ET | 2368 | 27.37 |
11:22 ET | 2458 | 27.41 |
11:24 ET | 4300 | 27.4206 |
11:26 ET | 4297 | 27.385 |
11:27 ET | 11936 | 27.37 |
11:29 ET | 3897 | 27.385 |
11:31 ET | 3700 | 27.385 |
11:33 ET | 5684 | 27.38 |
11:36 ET | 3201 | 27.375 |
11:38 ET | 3161 | 27.38 |
11:40 ET | 6857 | 27.4165 |
11:42 ET | 3590 | 27.405 |
11:44 ET | 1173 | 27.405 |
11:45 ET | 11350 | 27.4042 |
11:47 ET | 2253 | 27.405 |
11:49 ET | 500 | 27.405 |
11:51 ET | 1618 | 27.395 |
11:54 ET | 9087 | 27.4 |
11:56 ET | 877 | 27.395 |
11:58 ET | 405 | 27.395 |
12:00 ET | 1500 | 27.39 |
12:02 ET | 1516 | 27.39 |
12:03 ET | 1551 | 27.39 |
12:05 ET | 2443 | 27.375 |
12:07 ET | 4926 | 27.395 |
12:09 ET | 414 | 27.395 |
12:12 ET | 3100 | 27.38 |
12:14 ET | 737 | 27.38 |
12:16 ET | 500 | 27.38 |
12:18 ET | 8247 | 27.39 |
12:20 ET | 2240 | 27.355 |
12:21 ET | 10835 | 27.37 |
12:23 ET | 14327 | 27.335 |
12:25 ET | 54702 | 27.32 |
12:27 ET | 22856 | 27.385 |
12:30 ET | 8621 | 27.39 |
12:32 ET | 4200 | 27.4 |
12:34 ET | 2349 | 27.365 |
12:36 ET | 2295 | 27.365 |
12:38 ET | 5475 | 27.405 |
12:39 ET | 1449 | 27.395 |
12:41 ET | 5024 | 27.375 |
12:43 ET | 1976 | 27.375 |
12:45 ET | 1379 | 27.39 |
12:48 ET | 1711 | 27.415 |
12:50 ET | 5423 | 27.415 |
12:52 ET | 3401 | 27.405 |
12:54 ET | 2675 | 27.4 |
12:56 ET | 1336 | 27.42 |
12:57 ET | 408 | 27.425 |
12:59 ET | 510 | 27.4238 |
01:01 ET | 2530 | 27.425 |
01:03 ET | 10645 | 27.39 |
01:06 ET | 1829 | 27.395 |
01:08 ET | 900 | 27.39 |
01:10 ET | 3437 | 27.395 |
01:12 ET | 200 | 27.39 |
01:14 ET | 2827 | 27.38 |
01:15 ET | 2017 | 27.3754 |
01:17 ET | 4540 | 27.36 |
01:19 ET | 6183 | 27.365 |
01:21 ET | 4067 | 27.365 |
01:24 ET | 7255 | 27.395 |
01:26 ET | 1714 | 27.395 |
01:28 ET | 8625 | 27.405 |
01:30 ET | 1494 | 27.4008 |
01:32 ET | 1107 | 27.405 |
01:33 ET | 7280 | 27.375 |
01:35 ET | 2183 | 27.375 |
01:37 ET | 9861 | 27.385 |
01:39 ET | 5346 | 27.415 |
01:42 ET | 4671 | 27.435 |
01:44 ET | 8910 | 27.42 |
01:46 ET | 1177 | 27.425 |
01:48 ET | 1200 | 27.435 |
01:50 ET | 300 | 27.435 |
01:51 ET | 630 | 27.43 |
01:53 ET | 1531 | 27.425 |
01:55 ET | 6893 | 27.395 |
01:57 ET | 9645 | 27.39 |
02:00 ET | 14384 | 27.37 |
02:02 ET | 12857 | 27.34 |
02:04 ET | 7328 | 27.345 |
02:06 ET | 344 | 27.345 |
02:08 ET | 2566 | 27.355 |
02:09 ET | 2900 | 27.355 |
02:11 ET | 4157 | 27.37 |
02:13 ET | 2600 | 27.375 |
02:15 ET | 4012 | 27.335 |
02:18 ET | 3610 | 27.345 |
02:20 ET | 3500 | 27.345 |
02:22 ET | 2806 | 27.345 |
02:24 ET | 6279 | 27.355 |
02:26 ET | 1684 | 27.355 |
02:27 ET | 600 | 27.355 |
02:29 ET | 700 | 27.355 |
02:31 ET | 4305 | 27.385 |
02:33 ET | 17699 | 27.38 |
02:36 ET | 1336 | 27.375 |
02:38 ET | 1800 | 27.37 |
02:40 ET | 1200 | 27.36 |
02:42 ET | 5663 | 27.365 |
02:44 ET | 3748 | 27.365 |
02:45 ET | 6343 | 27.382 |
02:47 ET | 5394 | 27.375 |
02:49 ET | 500 | 27.375 |
02:51 ET | 6888 | 27.385 |
02:54 ET | 4245 | 27.365 |
02:56 ET | 3702 | 27.38 |
02:58 ET | 3273 | 27.385 |
03:00 ET | 1848 | 27.38 |
03:02 ET | 5095 | 27.395 |
03:03 ET | 6171 | 27.37 |
03:05 ET | 4872 | 27.33 |
03:07 ET | 1911 | 27.34 |
03:09 ET | 9900 | 27.36 |
03:12 ET | 3950 | 27.35 |
03:14 ET | 1316 | 27.35 |
03:16 ET | 5237 | 27.36 |
03:18 ET | 6380 | 27.35 |
03:20 ET | 2630 | 27.34 |
03:21 ET | 5502 | 27.335 |
03:23 ET | 6300 | 27.355 |
03:25 ET | 3075 | 27.335 |
03:27 ET | 3727 | 27.345 |
03:30 ET | 4471 | 27.335 |
03:32 ET | 7492 | 27.33 |
03:34 ET | 7034 | 27.3175 |
03:36 ET | 24388 | 27.31 |
03:38 ET | 10709 | 27.315 |
03:39 ET | 5308 | 27.305 |
03:41 ET | 25422 | 27.31 |
03:43 ET | 6205 | 27.295 |
03:45 ET | 11478 | 27.295 |
03:48 ET | 4407 | 27.295 |
03:50 ET | 6649 | 27.305 |
03:52 ET | 29402 | 27.29 |
03:54 ET | 19400 | 27.28 |
03:56 ET | 28993 | 27.29 |
03:57 ET | 54382 | 27.265 |
03:59 ET | 52428 | 27.27 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.3B | 15.3x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.1x | --- |
Catalent Inc | 10.0B | -8.5x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.5x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.0B | 2.2x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.08% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.3x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.